Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie S Belldegrun

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
BJU International|April 24, 2008
Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. IntroductionArie S Belldegrun, Paul Bevan
Nature Clinical Practice. Urology|December 7, 2007
Which pathological features of renal cell carcinoma have the greatest prognostic value?Jeffrey La Rochelle, Arie S Belldegrun
Current Urology Reports|March 12, 2011
Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complicationsDavid S Finley, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Salvage cryosurgery of the prostate after radiation failureJohn S Lam, Arie S Belldegrun
European Urology|March 19, 2011
Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and toleranceEdward N Rampersaud, Arie S Belldegrun
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes CzerninArie S Belldegrun, Ken Herrmann, Johannes Czernin
BJU International|April 24, 2008
Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategiesBrian Shuch, Zhenhua Li, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Report from the society of urologic oncology: highlights from the fourth annual meeting of the society of urologic oncology, december 5-6, 2003, bethesda, MDOleg Shvarts, John Lam, Arie S Belldegrun
Urologic Oncology|December 1, 2007
Update on partial nephrectomy and novel techniquesStephen B Riggs, Tobias Klatte, Arie S Belldegrun
BJU International|April 24, 2008
The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladderTobias Klatte, Arie S Belldegrun, Allan J Pantuck
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
BJU International|April 24, 2008
Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. IntroductionArie S Belldegrun, Paul Bevan
Nature Clinical Practice. Urology|December 7, 2007
Which pathological features of renal cell carcinoma have the greatest prognostic value?Jeffrey La Rochelle, Arie S Belldegrun
Current Urology Reports|March 12, 2011
Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complicationsDavid S Finley, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Salvage cryosurgery of the prostate after radiation failureJohn S Lam, Arie S Belldegrun
European Urology|March 19, 2011
Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and toleranceEdward N Rampersaud, Arie S Belldegrun
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes CzerninArie S Belldegrun, Ken Herrmann, Johannes Czernin
BJU International|April 24, 2008
Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategiesBrian Shuch, Zhenhua Li, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Report from the society of urologic oncology: highlights from the fourth annual meeting of the society of urologic oncology, december 5-6, 2003, bethesda, MDOleg Shvarts, John Lam, Arie S Belldegrun
Urologic Oncology|December 1, 2007
Update on partial nephrectomy and novel techniquesStephen B Riggs, Tobias Klatte, Arie S Belldegrun
BJU International|April 24, 2008
The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladderTobias Klatte, Arie S Belldegrun, Allan J Pantuck
Pageof 20